Latest from Food Politics: GLP-1 Drugs: A collection of items

More and more Americans are taking GLP-1 drugs; the current estimate is 11%. This causes a big problem for the food industry.   Eating less is bad for business. Here are some of the ways the food industry is responding. Analyzing the GLP-1 consumer ...

‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

By Marion Nestle September 17 2026 GLP-1 Drugs: A collection of items More and more Americans are taking GLP-1 drugs; the current estimate is 11%. This causes a big problem for the food industry.  Eating less is bad for business. Here are some of the ways the food industry is responding. Analyzing the GLP-1 consumer Overturning 7 industry assumptions about the GLP-1 consumer: The newest evidence challenges some of the food industry’s most comfortable conclusions about GLP-1 consumers… Read more New GLP-1 Consumer Data Challenges Food Industry Forecasts:  New data from IFF, PwC, BCG, and The Harris Poll UK challenges assumptions about GLP-1 consumers, bakery demand, grocery spending, and product development. Dealing with labeling issues What do consumers call GLP-1s? Manufacturers must understand how consumers talk about the drugs to improve marketing effectiveness, product discoverability and consumer engagement… Read more What does the ‘GLP-1 friendly’ label really mean?  Food companies are increasingly adopting the label on packaging, but failing to explain how it could help consumers on weight loss drugs, one industry expert writes. Beyond ‘GLP-1 friendly’: The nutrition opportunity food brands are missing: Health experts point to muscle, bone and cardiovascular health as key priorities for consumers taking GLP-1 medications and navigating midlife, creating opportunities for food and beverage brands to connect functional nutrition with consumer education… Read more Developing new products Can foods make consumers feel full like GLP-1s?  Many hope to replicate the impact of GLP-1s on satiety through food… Read more Nestlé bets big on GLP-1s with AI-powered nutrition push: The world’s biggest CPG is using AI and nutritional science to develop products tailored to GLP-1 users… Read more Europeans finally care about GLP-1s: Europe’s GLP-1 conversation is taking off. While uptake still trails the US, interest is surging across the continent… Read more _________________________ Arriving Sept 8. For a 30% discount, pre-order here using code UCPSAVE30. The post GLP-1 Drugs: A collection of items appeared first on Food Politics by Marion Nestle      Related Posts The effects of GLP-1 drugs on the food industry: A collection of recent items   Now Available: What to Eat Now My new book, What to Eat Now, is officially out! It's both a field guide to food shopping in America and a reflection on how to eat well—and deliciously. For more information and to order, click here. You can explore the full archive of this (almost) daily blog at foodpolitics.com, where you'll also find information about my books, articles, media interviews, upcoming lectures, favorite resources, and FAQs. Visit the Site » ​​​​​​​ Marion Nestle Paulette Goddard Professor of Nutrition, Food Studies, and Public Health at New York University, Emerita © Marion Nestle. You're receiving this email because you've signed up to receive updates from us. If you'd prefer not to receive updates, you can unsubscribe. Safely Unsubscribe • Archives • Preferences • Contact • Subscribe • Privacy

---

Email subscriptions powered by FeedBlitz® • 650 E. Palisade Avenue Ste 2, PO Box 173 • Englewood Cliffs, NJ 07632